The paper discusses several patent cases to argue that MNCs are aggressively asserting their patent rights not for getting genuine patents which they are entitled to but for preventing generic competi...
On 30 Mar 2015 The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals from 1 January, 2005. WIll this lead increase in resources deveoted to R and D by I...
On 31 Jul 2009 |